MEDLINE RENEWAL: payments to doctors
Payments that named MEDLINE RENEWAL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $508K
- Providers
- 0
- Transactions
- 227
- Average per transaction
- $2,238
The per-transaction average — $2,238 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medline Industries LP | $508,084 | 100.0% |